NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Model Medicines

Model Medicines

Private
San Diego, CaliforniaHealthcare & Life Scienceshttps://modelmedicines.com/

Last Round

Seed

Nov 14, 2025

Total Funding Raised

$4.1M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Model Medicines is a biotechnology company that develops AI-driven drug discovery platforms and therapeutics for oncology, infectious diseases, and other therapeutic areas.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Infrastructure

Keywords

AI drug discoverysmall-molecule therapeuticsgenerative AIin silico drug discoveryvirtual screeningpredictive toxicologybiotech AIdrug development platformmolecular modelingAI-first biotechpharmatechultra-large virtual screeningULVSmutagenicity predictiondrug pipeline

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Model Medicines Comparables

Compare Model Medicines with similar companies based on industry and business-model similarity.

Model Medicines comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

Model Medicines Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedNov 14, 2025
AcceleratorJun 12, 2025
AcceleratorMay 29, 2024
SeedNov 3, 2021

Key People

Founding team and executive leadership

Sean Russell

Co-founder, Chief Operating Officer And Head Of Discovery, Research And Development

Founding Team

Daniel Haders

Chief Executive Officer, Co-Founder, Board Director, Executive Chairman

Founding Team

Model Medicines Investors

Notable investors and investment history

Model Medicines investors
InvestorRounds
Nex CubedSeed
ParticleXSeed
MedTech InnovatorAccelerator
Irving InvestorsSeed
Public Health Emergency Medical Countermeasures EnterpriseAccelerator
BioTools InnovatorAccelerator
8VCSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 24, 2026

    Monthly visitors increased 40% MoM.

  • Mar 19, 2026

    CEO to present at the Artificial Intelligence Convergence Summit in Boston.

Model Medicines Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Model Medicines Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Model Medicines's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Diego, California
Employee Range16
Year Founded2019
Last FundingNov 14, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.